Tradestie Institutional Equity Comparison Engine

HERZ vs ABOS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HERZ Overall Edge

HERZ Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Herzfeld Credit Income Fund, Inc. Common Stock (HERZ) driven by superior Growth & Margin, Momentum & Technical while ABOS counters with relative strength in Options & Structure. Fundamentally, HERZ trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABOS at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, HERZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABOS sits in UNCLASSIFIED (41st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
HERZ N/M vs ABOS N/M Fwd P/E
Growth & Margin Winner HERZ
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner HERZ
1Y +404.3% vs -88.0% ยท 52W Pos 64% vs 1%
Options & Structure Winner ABOS
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (41st %ile IV)
HERZ NASDAQ
Herzfeld Credit Income Fund, Inc. Common Stock
Institutional Equity
$12.96
-0.31% 1D
Market Cap $40.2M
1M Return -13.18%
1Y Return +404.28%
Forward P/E N/M
Unified AI Score
48.7 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 59.0
ABOS NASDAQ
Acumen Pharmaceuticals, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.19
-3.52% 1D
Market Cap $14.0M
1M Return -90.95%
1Y Return -87.97%
Forward P/E N/M
Unified AI Score
49.2 / 100 HOLD
Tech 45.0 Fund 58.0 Flow 68.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HERZ +404.28% ABOS -87.97% Spread: +502.26 pp (HERZ Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HERZ TTM Op. Margin: 0.0% ABOS TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HERZ vs ABOS. Trailing 12-month operating profitability (HERZ 0.0% vs ABOS 0.0%) and valuation multiples (HERZ N/M vs ABOS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HERZ (4) vs ABOS (1)
Institutional Metric HERZ ABOS Criterion Row Winner
Market Capitalization Scale $40.2M $14.0M Larger Scale HERZ
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 0.0% -162.7% Higher ROE HERZ
52-Week Range Position Momentum 64% ($2โ€“$19) 1% ($0โ€“$4) Stronger Trend HERZ
Beta / 30D Volatility Risk Regime 0.26ฮฒ ยท 20% Vol 2.62ฮฒ ยท 326% Vol Lower Realized Risk HERZ
Unified Institutional Score Composite Signal 48.7 / 100 (HOLD) 49.2 / 100 (HOLD) Higher Composite ABOS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HERZ vs ABOS Buy Guide
HERZ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HERZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABOS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 41st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HERZ nor ABOS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.